FY21 consolidated facilities task order a
Ended Awarded Last action
- Contract number
- 75N91021F00003
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,482,789
Award facts
- Contract value 100% obligated
- $1,482,789.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,482,789 |
About this award
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $1.5 million cost-plus-fixed-fee delivery order contract to Leidos Biomedical Research Inc. for consolidated facilities task order support. Leidos Biomedical Research, a subsidiary of Leidos Holdings, will provide these services at its Fort Detrick, Maryland location to support the agency's research efforts. No set-aside designation or major subcontractors were indicated. This delivery order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle and will cover consolidated facilities management and operations services from February 2021 through December 2022 to aid the National Cancer Institute in achieving its mission to lead the nation's cancer research efforts.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| The Methodist Hospital | $3,800 |
Quick answers
Who was awarded contract 75N91021F00003?
75N91021F00003 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on February 4, 2021.
How much is contract 75N91021F00003 worth?
The government has obligated $1,482,789 on 75N91021F00003.
Is contract 75N91021F00003 an order under another contract?
Yes. 75N91021F00003 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91021F00003 competed?
The extent of competition for 75N91021F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award